A Distinct Metabolite Profile Correlates with Neurodegenerative Conditions and the Severity of Congenital Hydrocephalus

Abstract In congenital hydrocephalus, cerebrospinal fluid accumulation is associated with increased intracranial pressure (ICP), ischemia/hypoxia, metabolic impairment, neuronal damage, and astrocytic reaction. The aim of this study was to identify whether a metabolite profile revealing tissue respo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neuropathology and experimental neurology 2018-12, Vol.77 (12), p.1122-1136
Hauptverfasser: García-Bonilla, María, García-Martín, María L, Muñoz-Hernández, M Carmen, Domínguez-Pinos, Dolores, Martínez-León, María I, Peñalver, Ana, Castilla, Laura, Alonso, Francisco J, Márquez, Javier, Shumilov, Kirill, Hidalgo-Sánchez, Ramón, Gutiérrez, Antonia, Páez-González, Patricia, Jiménez, Antonio J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1136
container_issue 12
container_start_page 1122
container_title Journal of neuropathology and experimental neurology
container_volume 77
creator García-Bonilla, María
García-Martín, María L
Muñoz-Hernández, M Carmen
Domínguez-Pinos, Dolores
Martínez-León, María I
Peñalver, Ana
Castilla, Laura
Alonso, Francisco J
Márquez, Javier
Shumilov, Kirill
Hidalgo-Sánchez, Ramón
Gutiérrez, Antonia
Páez-González, Patricia
Jiménez, Antonio J
description Abstract In congenital hydrocephalus, cerebrospinal fluid accumulation is associated with increased intracranial pressure (ICP), ischemia/hypoxia, metabolic impairment, neuronal damage, and astrocytic reaction. The aim of this study was to identify whether a metabolite profile revealing tissue responses according to the severity of hydrocephalus can be detected. The hyh mutant mouse used for this study exhibits 2 different forms of hydrocephalus, severe and moderate. In a comprehensive investigation into the 2 progressions of hydrocephalus, mice with severe hydrocephalus were found to have higher ICP and astrocytic reaction. Several metabolites from the mouse brain cortex were analyzed with 1H high-resolution magic angle spinning nuclear magnetic resonance (1H HR-MAS NMR) spectroscopy. A differential profile for metabolites including glutamate and glutamine was found to correlate with the severity of hydrocephalus and can be explained due to differential astrocytic reactions, neurodegenerative conditions, and the presence of ischemia. The glutamate transporter EAAT2 and the metabolite taurine were found to be key histopathological markers of affected parenchymata. In conclusion, a differential metabolite profile can be detected according to the severity of hydrocephalus and associated ICP and therefore can be used to monitor the efficacy of experimental therapies.
doi_str_mv 10.1093/jnen/nly097
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2126904006</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A586026060</galeid><oup_id>10.1093/jnen/nly097</oup_id><sourcerecordid>A586026060</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4507-791ab893adc760edeb9b8860ef98dbf4fd0c9bde13ec80255c7c5c6b1c5406bc3</originalsourceid><addsrcrecordid>eNp9kd2L1DAUxYso7rj65LsEBBGkO7cfSZvHYfxYYf0A9Tmkye02YyYZk3SH-e9t6aooKnlIIL9z7uGeLHtcwEUBvFrvHLq1syfgzZ1sVVBa54w27d1sBVCWeQWMn2UPYtwBAAde38_OKqhYzXmxyo4b8tLEZJxK5B0m2XlrEpKPwffGItn6ENDKhJEcTRrIexyD13iNDoNM5mYmnDbJeBeJdJqkAcknvMFg0on4fv6eYJOkJZcnHbzCwyDtGB9m93ppIz66vc-zL69ffd5e5lcf3rzdbq5yVVNo8oYXsmt5JbVqGKDGjndtO7163uqur3sNincaiwpVCyWlqlFUsa5QtAbWqeo8e774HoL_NmJMYm-iQmulQz9GURYl41ADsAl9-ge682NwUzpRTgtrGaWs_kVdS4vCuN6nINVsKjZ0SlYyYDBRF3-hpqNxb5R3OG_3d8GLRaCCjzFgLw7B7GU4iQLEXLOYaxZLzRP95Dbq2O1R_2R_9DoB6wU4epswxK92PGIQA0qbhn9YPlsUfjz8d_Z3xJ3C0A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2303865564</pqid></control><display><type>article</type><title>A Distinct Metabolite Profile Correlates with Neurodegenerative Conditions and the Severity of Congenital Hydrocephalus</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>García-Bonilla, María ; García-Martín, María L ; Muñoz-Hernández, M Carmen ; Domínguez-Pinos, Dolores ; Martínez-León, María I ; Peñalver, Ana ; Castilla, Laura ; Alonso, Francisco J ; Márquez, Javier ; Shumilov, Kirill ; Hidalgo-Sánchez, Ramón ; Gutiérrez, Antonia ; Páez-González, Patricia ; Jiménez, Antonio J</creator><creatorcontrib>García-Bonilla, María ; García-Martín, María L ; Muñoz-Hernández, M Carmen ; Domínguez-Pinos, Dolores ; Martínez-León, María I ; Peñalver, Ana ; Castilla, Laura ; Alonso, Francisco J ; Márquez, Javier ; Shumilov, Kirill ; Hidalgo-Sánchez, Ramón ; Gutiérrez, Antonia ; Páez-González, Patricia ; Jiménez, Antonio J</creatorcontrib><description>Abstract In congenital hydrocephalus, cerebrospinal fluid accumulation is associated with increased intracranial pressure (ICP), ischemia/hypoxia, metabolic impairment, neuronal damage, and astrocytic reaction. The aim of this study was to identify whether a metabolite profile revealing tissue responses according to the severity of hydrocephalus can be detected. The hyh mutant mouse used for this study exhibits 2 different forms of hydrocephalus, severe and moderate. In a comprehensive investigation into the 2 progressions of hydrocephalus, mice with severe hydrocephalus were found to have higher ICP and astrocytic reaction. Several metabolites from the mouse brain cortex were analyzed with 1H high-resolution magic angle spinning nuclear magnetic resonance (1H HR-MAS NMR) spectroscopy. A differential profile for metabolites including glutamate and glutamine was found to correlate with the severity of hydrocephalus and can be explained due to differential astrocytic reactions, neurodegenerative conditions, and the presence of ischemia. The glutamate transporter EAAT2 and the metabolite taurine were found to be key histopathological markers of affected parenchymata. In conclusion, a differential metabolite profile can be detected according to the severity of hydrocephalus and associated ICP and therefore can be used to monitor the efficacy of experimental therapies.</description><identifier>ISSN: 0022-3069</identifier><identifier>EISSN: 1554-6578</identifier><identifier>DOI: 10.1093/jnen/nly097</identifier><identifier>PMID: 30364991</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Analysis ; Diagnostic imaging ; Genetic disorders ; Glutamate ; Glutamine ; Hydrocephalus ; Intracranial hypertension ; Intracranial pressure ; Ischemia ; Metabolites ; Neurons ; NMR ; Nuclear magnetic resonance ; Nuclear magnetic resonance spectroscopy ; Spectroscopy ; Taurine</subject><ispartof>Journal of neuropathology and experimental neurology, 2018-12, Vol.77 (12), p.1122-1136</ispartof><rights>2018 American Association of Neuropathologists, Inc. All rights reserved. 2018</rights><rights>2018 by American Association of Neuropathologists, Inc.</rights><rights>COPYRIGHT 2018 Oxford University Press</rights><rights>2018 American Association of Neuropathologists, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4507-791ab893adc760edeb9b8860ef98dbf4fd0c9bde13ec80255c7c5c6b1c5406bc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1578,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30364991$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>García-Bonilla, María</creatorcontrib><creatorcontrib>García-Martín, María L</creatorcontrib><creatorcontrib>Muñoz-Hernández, M Carmen</creatorcontrib><creatorcontrib>Domínguez-Pinos, Dolores</creatorcontrib><creatorcontrib>Martínez-León, María I</creatorcontrib><creatorcontrib>Peñalver, Ana</creatorcontrib><creatorcontrib>Castilla, Laura</creatorcontrib><creatorcontrib>Alonso, Francisco J</creatorcontrib><creatorcontrib>Márquez, Javier</creatorcontrib><creatorcontrib>Shumilov, Kirill</creatorcontrib><creatorcontrib>Hidalgo-Sánchez, Ramón</creatorcontrib><creatorcontrib>Gutiérrez, Antonia</creatorcontrib><creatorcontrib>Páez-González, Patricia</creatorcontrib><creatorcontrib>Jiménez, Antonio J</creatorcontrib><title>A Distinct Metabolite Profile Correlates with Neurodegenerative Conditions and the Severity of Congenital Hydrocephalus</title><title>Journal of neuropathology and experimental neurology</title><addtitle>J Neuropathol Exp Neurol</addtitle><description>Abstract In congenital hydrocephalus, cerebrospinal fluid accumulation is associated with increased intracranial pressure (ICP), ischemia/hypoxia, metabolic impairment, neuronal damage, and astrocytic reaction. The aim of this study was to identify whether a metabolite profile revealing tissue responses according to the severity of hydrocephalus can be detected. The hyh mutant mouse used for this study exhibits 2 different forms of hydrocephalus, severe and moderate. In a comprehensive investigation into the 2 progressions of hydrocephalus, mice with severe hydrocephalus were found to have higher ICP and astrocytic reaction. Several metabolites from the mouse brain cortex were analyzed with 1H high-resolution magic angle spinning nuclear magnetic resonance (1H HR-MAS NMR) spectroscopy. A differential profile for metabolites including glutamate and glutamine was found to correlate with the severity of hydrocephalus and can be explained due to differential astrocytic reactions, neurodegenerative conditions, and the presence of ischemia. The glutamate transporter EAAT2 and the metabolite taurine were found to be key histopathological markers of affected parenchymata. In conclusion, a differential metabolite profile can be detected according to the severity of hydrocephalus and associated ICP and therefore can be used to monitor the efficacy of experimental therapies.</description><subject>Analysis</subject><subject>Diagnostic imaging</subject><subject>Genetic disorders</subject><subject>Glutamate</subject><subject>Glutamine</subject><subject>Hydrocephalus</subject><subject>Intracranial hypertension</subject><subject>Intracranial pressure</subject><subject>Ischemia</subject><subject>Metabolites</subject><subject>Neurons</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Nuclear magnetic resonance spectroscopy</subject><subject>Spectroscopy</subject><subject>Taurine</subject><issn>0022-3069</issn><issn>1554-6578</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp9kd2L1DAUxYso7rj65LsEBBGkO7cfSZvHYfxYYf0A9Tmkye02YyYZk3SH-e9t6aooKnlIIL9z7uGeLHtcwEUBvFrvHLq1syfgzZ1sVVBa54w27d1sBVCWeQWMn2UPYtwBAAde38_OKqhYzXmxyo4b8tLEZJxK5B0m2XlrEpKPwffGItn6ENDKhJEcTRrIexyD13iNDoNM5mYmnDbJeBeJdJqkAcknvMFg0on4fv6eYJOkJZcnHbzCwyDtGB9m93ppIz66vc-zL69ffd5e5lcf3rzdbq5yVVNo8oYXsmt5JbVqGKDGjndtO7163uqur3sNincaiwpVCyWlqlFUsa5QtAbWqeo8e774HoL_NmJMYm-iQmulQz9GURYl41ADsAl9-ge682NwUzpRTgtrGaWs_kVdS4vCuN6nINVsKjZ0SlYyYDBRF3-hpqNxb5R3OG_3d8GLRaCCjzFgLw7B7GU4iQLEXLOYaxZLzRP95Dbq2O1R_2R_9DoB6wU4epswxK92PGIQA0qbhn9YPlsUfjz8d_Z3xJ3C0A</recordid><startdate>201812</startdate><enddate>201812</enddate><creator>García-Bonilla, María</creator><creator>García-Martín, María L</creator><creator>Muñoz-Hernández, M Carmen</creator><creator>Domínguez-Pinos, Dolores</creator><creator>Martínez-León, María I</creator><creator>Peñalver, Ana</creator><creator>Castilla, Laura</creator><creator>Alonso, Francisco J</creator><creator>Márquez, Javier</creator><creator>Shumilov, Kirill</creator><creator>Hidalgo-Sánchez, Ramón</creator><creator>Gutiérrez, Antonia</creator><creator>Páez-González, Patricia</creator><creator>Jiménez, Antonio J</creator><general>Oxford University Press</general><general>by American Association of Neuropathologists, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>201812</creationdate><title>A Distinct Metabolite Profile Correlates with Neurodegenerative Conditions and the Severity of Congenital Hydrocephalus</title><author>García-Bonilla, María ; García-Martín, María L ; Muñoz-Hernández, M Carmen ; Domínguez-Pinos, Dolores ; Martínez-León, María I ; Peñalver, Ana ; Castilla, Laura ; Alonso, Francisco J ; Márquez, Javier ; Shumilov, Kirill ; Hidalgo-Sánchez, Ramón ; Gutiérrez, Antonia ; Páez-González, Patricia ; Jiménez, Antonio J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4507-791ab893adc760edeb9b8860ef98dbf4fd0c9bde13ec80255c7c5c6b1c5406bc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Analysis</topic><topic>Diagnostic imaging</topic><topic>Genetic disorders</topic><topic>Glutamate</topic><topic>Glutamine</topic><topic>Hydrocephalus</topic><topic>Intracranial hypertension</topic><topic>Intracranial pressure</topic><topic>Ischemia</topic><topic>Metabolites</topic><topic>Neurons</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Nuclear magnetic resonance spectroscopy</topic><topic>Spectroscopy</topic><topic>Taurine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>García-Bonilla, María</creatorcontrib><creatorcontrib>García-Martín, María L</creatorcontrib><creatorcontrib>Muñoz-Hernández, M Carmen</creatorcontrib><creatorcontrib>Domínguez-Pinos, Dolores</creatorcontrib><creatorcontrib>Martínez-León, María I</creatorcontrib><creatorcontrib>Peñalver, Ana</creatorcontrib><creatorcontrib>Castilla, Laura</creatorcontrib><creatorcontrib>Alonso, Francisco J</creatorcontrib><creatorcontrib>Márquez, Javier</creatorcontrib><creatorcontrib>Shumilov, Kirill</creatorcontrib><creatorcontrib>Hidalgo-Sánchez, Ramón</creatorcontrib><creatorcontrib>Gutiérrez, Antonia</creatorcontrib><creatorcontrib>Páez-González, Patricia</creatorcontrib><creatorcontrib>Jiménez, Antonio J</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neuropathology and experimental neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>García-Bonilla, María</au><au>García-Martín, María L</au><au>Muñoz-Hernández, M Carmen</au><au>Domínguez-Pinos, Dolores</au><au>Martínez-León, María I</au><au>Peñalver, Ana</au><au>Castilla, Laura</au><au>Alonso, Francisco J</au><au>Márquez, Javier</au><au>Shumilov, Kirill</au><au>Hidalgo-Sánchez, Ramón</au><au>Gutiérrez, Antonia</au><au>Páez-González, Patricia</au><au>Jiménez, Antonio J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Distinct Metabolite Profile Correlates with Neurodegenerative Conditions and the Severity of Congenital Hydrocephalus</atitle><jtitle>Journal of neuropathology and experimental neurology</jtitle><addtitle>J Neuropathol Exp Neurol</addtitle><date>2018-12</date><risdate>2018</risdate><volume>77</volume><issue>12</issue><spage>1122</spage><epage>1136</epage><pages>1122-1136</pages><issn>0022-3069</issn><eissn>1554-6578</eissn><abstract>Abstract In congenital hydrocephalus, cerebrospinal fluid accumulation is associated with increased intracranial pressure (ICP), ischemia/hypoxia, metabolic impairment, neuronal damage, and astrocytic reaction. The aim of this study was to identify whether a metabolite profile revealing tissue responses according to the severity of hydrocephalus can be detected. The hyh mutant mouse used for this study exhibits 2 different forms of hydrocephalus, severe and moderate. In a comprehensive investigation into the 2 progressions of hydrocephalus, mice with severe hydrocephalus were found to have higher ICP and astrocytic reaction. Several metabolites from the mouse brain cortex were analyzed with 1H high-resolution magic angle spinning nuclear magnetic resonance (1H HR-MAS NMR) spectroscopy. A differential profile for metabolites including glutamate and glutamine was found to correlate with the severity of hydrocephalus and can be explained due to differential astrocytic reactions, neurodegenerative conditions, and the presence of ischemia. The glutamate transporter EAAT2 and the metabolite taurine were found to be key histopathological markers of affected parenchymata. In conclusion, a differential metabolite profile can be detected according to the severity of hydrocephalus and associated ICP and therefore can be used to monitor the efficacy of experimental therapies.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>30364991</pmid><doi>10.1093/jnen/nly097</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-3069
ispartof Journal of neuropathology and experimental neurology, 2018-12, Vol.77 (12), p.1122-1136
issn 0022-3069
1554-6578
language eng
recordid cdi_proquest_miscellaneous_2126904006
source Oxford University Press Journals All Titles (1996-Current); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Analysis
Diagnostic imaging
Genetic disorders
Glutamate
Glutamine
Hydrocephalus
Intracranial hypertension
Intracranial pressure
Ischemia
Metabolites
Neurons
NMR
Nuclear magnetic resonance
Nuclear magnetic resonance spectroscopy
Spectroscopy
Taurine
title A Distinct Metabolite Profile Correlates with Neurodegenerative Conditions and the Severity of Congenital Hydrocephalus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T18%3A37%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Distinct%20Metabolite%20Profile%20Correlates%20with%20Neurodegenerative%20Conditions%20and%20the%20Severity%20of%20Congenital%20Hydrocephalus&rft.jtitle=Journal%20of%20neuropathology%20and%20experimental%20neurology&rft.au=Garc%C3%ADa-Bonilla,%20Mar%C3%ADa&rft.date=2018-12&rft.volume=77&rft.issue=12&rft.spage=1122&rft.epage=1136&rft.pages=1122-1136&rft.issn=0022-3069&rft.eissn=1554-6578&rft_id=info:doi/10.1093/jnen/nly097&rft_dat=%3Cgale_proqu%3EA586026060%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2303865564&rft_id=info:pmid/30364991&rft_galeid=A586026060&rft_oup_id=10.1093/jnen/nly097&rfr_iscdi=true